Literature DB >> 16148066

Development of the cardiac conduction system in atrioventricular septal defect in human trisomy 21.

Nico A Blom1, Jaap Ottenkamp, Marco C Deruiter, Arnold C G Wenink, Adriana C Gittenberger-de Groot.   

Abstract

In patients with atrioventricular septal defect (AVSD), the occurrence of nonsurgical AV block has been reported. We have looked for an explanation in the development of the AV conduction system. Human embryos with AVSD and trisomy 21 and normal embryos were examined (age 5-16 wk gestation). Antibodies to human natural killer cell-1 (HNK-1), muscle actin (HHF-35), and collagen VI were used to delineate the conduction system. As in normal hearts, HNK-1 transiently stains the AV conduction system, the sinoatrial node, and parts of the sinus venosus in AVSD. A large distance is present between the superior and inferior node-like part of the right AV ring bundle, comparable to 6-wk-old normal hearts. The definitive inferior AV node remains in dorsal position from 7 wk onward and does not appose to the superior node-like part as seen in normal hearts. Furthermore, in AVSD, a transient third HNK-1-positive "middle bundle" branch that is continuous with the retroaortic root branch and the superior node-like part can be identified, and thus the AV conduction system forms a figure-of-eight loop. At later stages, the AV node remains in dorsal position close to the coronary sinus ostium with a long nonbranching bundle that runs through thin fibrous tissue toward the ventricular septum. The formation of the AV node and the ventricular conduction system in AVSD and Down syndrome differs from normal development, which can be a causative factor in the development of AV conduction disturbances.

Entities:  

Mesh:

Year:  2005        PMID: 16148066     DOI: 10.1203/01.PDR.0000179388.10921.44

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Increased P-wave and QT dispersions necessitate long-term follow-up evaluation of Down syndrome patients with congenitally normal hearts.

Authors:  Cem Karadeniz; Rahmi Ozdemir; Fikri Demir; Yılmaz Yozgat; Mehmet Küçük; Talia Oner; Utku Karaarslan; Timur Meşe; Nurettin Unal
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

2.  Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database.

Authors:  James C Fudge; Shuang Li; James Jaggers; Sean M O'Brien; Eric D Peterson; Jeffrey P Jacobs; Karl F Welke; Marshall L Jacobs; Jennifer S Li; Sara K Pasquali
Journal:  Pediatrics       Date:  2010-07-12       Impact factor: 7.124

3.  Bradyarrhythmias in Repaired Atrioventricular Septal Defects: Single-Center Experience Based on 34 Years of Follow-Up of 522 Patients.

Authors:  Corrado Di Mambro; Camilla Calvieri; Massimo Stefano Silvetti; Ilaria Tamburri; Salvatore Giannico; Anwar Baban; Sonia Albanese; Gianluca Brancaccio; Adriano Carotti; Fiore Salvatore Iorio; Fabrizio Drago
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

4.  The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model.

Authors:  Matthieu Raveau; Jacques M Lignon; Valérie Nalesso; Arnaud Duchon; Yoram Groner; Andrew J Sharp; Doulaye Dembele; Véronique Brault; Yann Hérault
Journal:  PLoS Genet       Date:  2012-05-31       Impact factor: 5.917

Review 5.  Development and evolution of the metazoan heart.

Authors:  Robert E Poelmann; Adriana C Gittenberger-de Groot
Journal:  Dev Dyn       Date:  2019-05-20       Impact factor: 3.780

6.  First in situ 3D visualization of the human cardiac conduction system and its transformation associated with heart contour and inclination.

Authors:  Tomokazu Kawashima; Fumi Sato
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

7.  Late-presenting complete heart block after pediatric cardiac surgery.

Authors:  Bana Agha Nasser; Abdu Rahman Mesned; Tagelden Mohamad; Mohamad S Kabbani
Journal:  J Saudi Heart Assoc       Date:  2015-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.